Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR: Adalimumab + Methotrexate in Psoriasis
NCT02196701Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2014
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by AbbVie Inc.. Started Aug 2014; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02196701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196701.